Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2025 FYStats 
Home
Equities
IMMX
Fundamentals

Immix Biopharma, Inc.

IMMX

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

20.00M
▲20.00M∞%
-

Assets

19.89M
▼-3.06M▼-13.32%
3 Months Change

Liabilities

10.30M
▲601.82k▲6.21%
3 Months Change

Free Cash Flow

-1.75M
▲2.38M▲57.55%
12 Months Change

Revenue/Cost Of Revenue

Loading...

Net Profit/Loss

Loading...

Assets/Liabilities

Loading...

Cash Flows

Loading...

Earnings Per Share

Loading...

Outstanding Shares

Loading...

Recent Quarterly and Annual Filings

2024-08-12
Form 10-Q
ID: 0001493152-24-031358
2024-07-26
Form 8-K
ID: 0001493152-24-029174
2024-07-22
Form 8-K
ID: 0001493152-24-028595
2024-06-14
Form 8-K
ID: 0001493152-24-023947
2024-05-20
Form 8-K
ID: 0001493152-24-020785
2024-05-09
Form 10-Q
ID: 0001493152-24-018458
2024-02-06
Form 8-K
ID: 0001493152-24-005043
2024-02-05
Form 8-K
ID: 0001493152-24-004933
2023-11-13
Form 10-Q
ID: 0001493152-23-040182
2023-08-22
Form 8-K
ID: 0001493152-23-029822